Physician profile
David D Edalati
NPI 1477669141
$21,378.24
in general payments reported to CMS, 2019-2025
100 companies · $3,824 in 2025
The $3,824 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,547 · 2020: $1,008 · 2021: $2,580 · 2022: $3,161 · 2023: $3,784 · 2024: $3,475 · 2025: $3,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,065.54 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,313.01 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $1,533.58 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $1,241.61 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $1,214.65 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $1,121.69 | 2019-2025 | |
| Glaxosmithkline, LLC. | $917.56 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $908.80 | 2019-2024 | Verquvo, Dificid, Zerbaxa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $790.43 | 2022-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $767.36 | 2019-2025 | Rexulti, Abilify Maintena, Nuedexta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $673.75 | 2019-2025 | Jardiance, Ofev |
| Axsome Therapeutics, INC. | $634.13 | 2022-2025 | Auvelity, Symbravo |
| Viiv Healthcare Company | $549.36 | 2019-2025 | Dovato, Cabenuva |
| Sunovion Pharmaceuticals INC. | $395.09 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $377.23 | 2019-2025 | Trintellix |
| Antares Pharma, INC. | $359.72 | 2019-2025 | Xyosted, Nocdurna, Tlando |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $357.92 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $353.50 | 2019-2023 | Spravato |
| Melinta Therapeutics, LLC | $345.17 | 2019-2025 | Kimyrsa, Rezzayo, Orbactiv |
| Bayer Healthcare Pharmaceuticals INC. | $311.19 | 2021-2024 | |
| Abbott Laboratories | $304.75 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Organogenesis INC. | $301.44 | 2020-2023 | Puraply |
| Amgen INC. | $264.77 | 2019-2025 | Otezla, Repatha, Prolia |
| Collegium Pharmaceutical, INC. | $260.84 | 2021-2025 | Belbuca, Xtampza |
| Ardelyx, INC. | $251.82 | 2024-2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $222.99 | 2019-2025 | Xifaxan |
| Amarin Pharma, INC. | $203.46 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $188.79 | 2022-2023 | Quviviq |
| Almatica Pharma LLC | $178.04 | 2023-2025 | Loreev Xr, Gralise |
| Allergan, INC. | $171.50 | 2019-2020 | |
| Insmed, INC. | $161.69 | 2019-2025 | Brinsupri, Arikayce |
| Biodelivery Sciences International, INC. | $160.80 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $141.70 | 2019-2022 | |
| Mylan Specialty L.P. | $136.16 | 2019-2024 | Yupelri |
| Clarus Therapeutics INC. | $136.11 | 2021 | |
| Shield Therapeutics INC | $131.91 | 2025 | |
| Supernus Pharmaceuticals, INC. | $131.34 | 2020-2024 | Xyosted, Tlando, Qelbree |
| Vanda Pharmaceuticals INC. | $124.18 | 2019-2024 | Fanapt, Hetlioz |
| E.R. Squibb & Sons, L.L.C. | $110.59 | 2019-2025 | Eliquis |
| Grt US Holding, INC. | $100.87 | 2022 | |
| Eisai INC. | $98.02 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $96.83 | 2019-2024 | Linzess |
| Acelrx Pharmaceuticals, INC. | $96.59 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $94.37 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $85.07 | 2024-2025 | Nuzyra |
| Scilex Pharmaceuticals INC. | $84.50 | 2019-2020 | |
| Astellas Pharma US INC | $83.36 | 2019-2025 | Veozah |
| Zyla Life Sciences, INC. | $81.46 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $76.90 | 2019-2022 | |
| Biogen, INC. | $75.68 | 2021 | |
| Kyowa Kirin, INC. | $71.96 | 2020-2024 | Crysvita |
| Arbor Pharmaceuticals, INC. | $71.22 | 2019-2022 | |
| Azurity Pharmaceuticals, INC. | $71.17 | 2023-2025 | Horizant, Azmiro, Horizant |
| Convatec INC. | $70.21 | 2023-2025 | |
| Mallinckrodt Hospital Products INC. | $64.54 | 2020-2024 | Acthar |
| Horizon Therapeutics Plc | $64.34 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $63.52 | 2022 | |
| Phathom Pharmaceuticals, INC. | $56.82 | 2024 | Voquezna |
| Amneal Pharmaceuticals LLC | $50.90 | 2022-2024 | Unithroid |
| Verona Pharma, INC. | $46.79 | 2025 | Ohtuvayre |
| Next Science LLC | $46.55 | 2023-2024 | Surgx, Blastx, Xperience |
| Viatris Specialty LLC | $42.42 | 2025 | Yupelri |
| Protega Pharmaceutials INC | $42.03 | 2025 | Roxybond |
| Mannkind Corporation | $41.61 | 2019 | |
| Exact Sciences Corporation | $41.18 | 2024 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $40.37 | 2022-2025 | Zoryve |
| Gilead Sciences, INC. | $35.35 | 2019-2021 | |
| Corium, LLC | $33.76 | 2023 | Azstarys |
| Halozyme INC | $32.10 | 2023 | |
| Harmony Biosciences LLC | $31.83 | 2023 | Wakix |
| Vifor Pharma, INC. | $31.06 | 2019 | |
| Ferring Pharmaceuticals INC. | $30.58 | 2023 | Rebyota |
| Smith+Nephew, INC. | $30.29 | 2019-2020 | |
| Nabriva Therapeutics, Plc | $29.46 | 2021 | |
| Cequr Corporation | $28.88 | 2023 | Cequr Simplicity |
| Inspire Medical Systems, INC. | $28.29 | 2025 | Inspire |
| Kerecis Limited | $27.42 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $25.83 | 2022 | |
| Curonix LLC | $24.32 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Neurocrine Biosciences, INC. | $24.21 | 2023 | Ingrezza |
| Optinose US, INC. | $24.03 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $21.36 | 2021 | |
| Janssen Biotech, INC. | $20.31 | 2021 | |
| Shionogi INC | $20.12 | 2019 | |
| Xeris Pharmaceuticals, INC. | $19.82 | 2025 | Gvoke Hypopen |
| Vertical Pharmaceuticals, LLC | $19.68 | 2019 | |
| Neuronetics, INC. | $19.39 | 2020 | |
| Tolmar, INC. | $18.10 | 2024 | |
| Tersera Therapeutics LLC | $17.75 | 2019 | |
| Medtronic Minimed, INC. | $16.91 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $16.77 | 2019 | |
| Genentech USA, INC. | $16.70 | 2019 | |
| Esperion Therapeutics, INC. | $16.48 | 2024 | Nexletol |
| Electromed, INC. | $14.24 | 2025 | Smartvest |
| Verity Pharmaceuticals INC. | $13.57 | 2025 | Tlando |
| Jazz Pharmaceuticals INC. | $13.43 | 2019 | |
| Forte Bio-Pharma LLC | $13.36 | 2024 | Prolate, Nalocet |
| Lundbeck LLC | $12.61 | 2022 | |
| Vistapharm, INC. | $12.30 | 2021 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Edalati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.